Callie Care, a Delaware-based AgeTech startup, has raised $500,000 in pre-seed funding from angel investors alongside non-dilutive support from InterSystems Ventures. The company is developing a phone-first voice AI companion designed to call older adults daily, help manage routine needs, and keep families and care teams informed. Its funding comes as the United States faces growing pressure on senior care systems, with more older people living independently and family caregivers carrying much of the responsibility.
A Phone-First Model for Aging at Home
Founded in 2025, Callie Care was created by Igor Gurovich, Yury Palevich, and Michil Androsov, whose personal experiences with aging relatives informed the company’s approach. Rather than requiring seniors to download an app, learn a new interface, or use additional hardware, the service operates through standard telephone calls. The platform is intended to offer practical and social support through a device that most older adults already know how to use.
Daily Assistance and Wellness Support
During daily calls, Callie Care can help users arrange transportation, order groceries and medications, schedule appointments, and receive reminders about everyday tasks. The voice assistant is also designed to remember previous conversations, adapt to each user’s preferences, and provide companionship through discussions, activities, and new topics. According to the company, the system can connect conversations with a user’s health profile, routines, family members, doctors, and caregivers.
Data-Driven Insights for Families and Care Providers
Callie Care uses multiple AI models and retrieval-augmented generation technology to maintain context and personalize conversations over time. The company says its platform can identify health and wellness signals from natural dialogue, including indications of pain, low mood, loneliness, medication concerns, or unmet practical needs. Families can receive weekly wellness updates, while care organizations can be alerted to issues that may require clinical or operational follow-up.
Early Adoption and Enterprise Ambitions
The startup said more than 8,000 users had tried its service since the launch of its minimum viable product in mid-October 2025. It reported that 85% of engaged users asked to continue receiving regular calls, while average conversations lasted about 10 minutes. Callie Care also said that many users voluntarily discussed health, medications, symptoms, anxiety, sadness, or loneliness during calls, creating a basis for longitudinal wellness profiles.
Expanding Cognitive Monitoring Capabilities
A longer-term part of Callie Care’s strategy involves developing passive voice biomarker analysis to identify potential signs of cognitive decline through speech patterns. The company argues that earlier identification could help address delays in the diagnosis of mild cognitive impairment and dementia, although such capabilities will require careful clinical validation and responsible deployment. The startup plans to build infrastructure that can support advanced monitoring while integrating with healthcare and senior care systems.
Funding Deployment and Market Opportunity
Callie Care plans to use the pre-seed funding to release its next product version, expand user acquisition, strengthen its technical infrastructure, and develop enterprise sales channels. The company is targeting home care agencies, senior living communities, value-based care providers, and insurance reimbursement pathways, while its acceptance into the VA Innovation Repository could open opportunities in the veteran care market. InterSystems Ventures’ support will be directed toward creating scalable and interoperable infrastructure for health system integration.
Callie Care is positioning its phone-first AI platform as an additional support layer for older adults who want to remain independent without adding complexity to their daily routines. Its approach reflects a broader effort to use conversational AI to extend the reach of families, caregivers, and healthcare providers rather than replace them. With fresh funding and early user engagement, the company now faces the challenge of translating initial demand into a scalable, clinically responsible senior care platform.